Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19)

Clinical Application and Theoretical Discussion of Fuzheng Qingfei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030896

Enrollment

Unknown

Registered

2020-03-16

Start date

2020-02-06

Completion date

Unknown

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:traditional Chinese medicine and Western medicine treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Pneumonitis patients infected with new coronavirus; 2. Meet the standard of TCM syndrome differentiation; 3. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Complicated active tuberculosis, malignant arrhythmia, acute myocardial infarction, stroke, etc. 2. pregnant and lactating women; 3. Combining severe cognitive and mental disorders; 4. Clinical researchers who are participating in other interventions within 1 month before being selected; 5. Those who are known to be allergic to treatment drugs; 6. Those who are critically ill. 7. The researcher thinks that others are not suitable for enrollment.

Design outcomes

Primary

Measure	Time frame
Improvement of symptoms;	—

Countries

China

Contacts

Public ContactWang Dazhong

Zhengzhou People's Hospital

13803818341@163.com+86 13803818341

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026